Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension

Published:2023-09 Issue: Volume:329 Page:121988
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Braga Cássia Lisboa,Santos Renata Trabach,da Silva Carla Medeiros,de Novaes Rocha Nazareth,Felix Nathane Santanna,Medeiros Mayck,Melo Monique Martins,Silva Johnatas Dutra,Teixeira Douglas Esteves,Neves Celso Caruso,Rocco Patricia Rieken Macedo,Cruz Fernanda Ferreira,Silva Pedro Leme

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference83 articles.

1. Pulmonary arterial hypertension: diagnosis, treatment, and novel advances;Maron;Am. J. Respir. Crit. Care Med.,2021

2. Perivascular inflammation in pulmonary arterial hypertension;Hu;Cells,2020

3. New and emerging therapies for pulmonary arterial hypertension;Spiekerkoetter;Annu. Rev. Med.,2019

4. Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report;Klinger;Chest,2019

5. Inflammatory basis of pulmonary arterial hypertension: implications for perioperative and critical care medicine;Goldenberg;Anesthesiology,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct effects of intravenous bone marrow-derived mesenchymal stem cell therapy on ischemic and non-ischemic lungs after ischemia-reperfusion injury;Cytotherapy;2024-07